Skip to main content
Skip to content
Case File
efta-efta00489740DOJ Data Set 9Other

From: Lesley Groff

Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00489740
Pages
2
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Lesley Groff To: Jefffrey Epstein <jeevacation@gmail.com>, Rich Kahn < Subject: Date: Thu, 17 Jan 2019 17:19:49 +0000 Inline-Images: 1506365439123blobjpg; 1506365439123blob(1).jpg > equested I forward you the below 'catch up' email. BioHcbe LLC cell: email: www.biohebe.com 011itoHehe ;11nline image -- Forwarded Message --- From To: je . leevacation@gmail.com>; Sent: Wednesday, January 16, 2019, 11:22:06 PM EST Subject: Catching Up Dear Jeffrey I hope you've been well. I wanted to update you on what I've been up to for the last two years. I was also hoping to talk with you to see if I might use the foundation's Lexington office conference room from time to time for my work and what I could provide in exchange for that. I am cc'ing Rich because I'm not sure if you still use this email? Since working for your foundation, I continued to publish as a joumalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapies are genetic vectors, and have to show remarkable results at the mouse level and beyond. Regenerative medicine is a rapidly evolving field, and one that forces the medical industry to shift their focus from addressing symptoms of disease to fundamental evolutionary shortfalls. So far, I placed a genetic vector at the National Institute of Medicine in France (that reversed glaucoma in mice using the neuroglobin gene) under formal licence review with a publicly traded pharma group here in the US. And I am collaborating with a lab at the University of Pittsburgh that has reversed cirrhosis/ end stage liver disease in rats using the master transcription gene in hepatocytes. The concept of the latter gene vector is really EFTA00489740 intriguing in that a master transcription gene completely restored liver function by rebalancing genetic expression and thus proteostasis. While I don't really need an office at this point, I do need access to a conference mom from time to time and it would be hugely helpful if I could access the foundation's. If there was some work that I could do for the foundation in exchange, I would be delighted to do that. It would be wonderful to catch up with you as well. all the best, BioHebe LLC cell: email: www.biohebe.com ceBioHebe ;Janne image EFTA00489741

Technical Artifacts (3)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Domainwww.biohebe.com
Emailjeevacation@gmail.com
Emailleevacation@gmail.com

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.